Monthly Archives: July 2011

AMC v. Myriad – “Laws of Nature” Exception Does Not Include Isolated DNA

As noted in my last “flash” post, a divided three-judge Fed. Cir. panel (Judges Lourie, Bryson and Moore) issued an opinion holding that the isolated DNA sequences and the drug-screening method claimed by Myriad are patentable subject matter, not natural … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , , , | 1 Comment

Divided Panel Finds DNA Molecules Patentable – Cancer Screening Claims Too Abstract

Today a divided Fed. Cir. panel of Judges Lourie, Moore and Bryson – Lourie writing for the “majority” – reversed the district court judge, in AMP v. Myriad, holding that isolated DNA sequences are patent-eligible subject matter and not natural … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , , , | Leave a comment

District Court Dismisses Stem Cell Ban Suit

On July 27, in Sherley v. Sibelius, Judge Royce Lamberth reversed himself, and dismissed the 2010 lawsuit that initially led to a freeze on Government funding for human embryonic stem cell research, conducted under the terms of the 2009 NIH … Continue reading

Posted in Stem Cells/Cloning | Tagged , , , , , | Leave a comment

Inequitable Conduct in Canada – Disarming the “Atomic Bomb”

This is a guest post from Brian W. Gray of Norton Rose. This week a significant decision for patent owners was released from our Canadian Federal Court of Appeal. A copy of the case is found at the end of … Continue reading

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , , , , , , , , , , , | 1 Comment